Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - BlackRock profits from clinic joint venture agreement with Humana

BUZZ - BlackRock profits from clinic joint venture agreement with Humana

路透社路透社2026/10/13 12:02
Show original

- ** Health insurance company Humana (HUM.N) shares rose 1.39% to $439.5; asset management firm BlackRock (BLK.N) rose 1.58% in pre-market trading to $1,101.01

** According to filings from the U.S. Securities and Exchange Commission (SEC), HUM and BLK formed a joint venture (link) to manage 150 CenterWell primary care clinics

** BlackRock will acquire approximately $2.8 billion in equity held by private equity firm Welsh, Carson, Anderson & Stowe in the HUM subsidiary CenterWell clinic joint venture

** The transaction is expected to be completed in the fourth quarter of 2026

** HUM reaffirmed its adjusted earnings per share (EPS) outlook of at least $9 for fiscal year 2026—according to SEC filings

** As of the previous trading day's close, shares of HUM and BLK have risen 69.3% and 1.2% respectively so far this year


(To assist non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text. Automated translations are provided solely for reader convenience. Reuters accepts no responsibility for any damage or loss arising from the use of this automated translation function.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs dramatically lowers KOSPI target from 12,000 to 9,000 points, still insists there is 60% upside potential

Goldman Sachs strategists have lowered their 12-month target for South Korea's KOSPI Index from 12,000 points to 9,000 points, representing a 25% decrease. Earlier this year, Goldman had raised the target multiple times. The latest downgrade is due to mounting concerns in the market over artificial intelligence (AI) trading.

智通财经•2026/10/25 10:51
Goldman Sachs dramatically lowers KOSPI target from 12,000 to 9,000 points, still insists there is 60% upside potential